Key result
Prior outpatient statin or ARB use linked to ~52% lower 30-day mortality in sepsis.
Why the study?
The effect of previous outpatient use of statins and/or angiotensin II receptor blockers on 30-day mortality in patients hospitalized with sepsis was unclear.
Does previous outpatient use of statins and/or ARBs reduce 30-day mortality in patients hospitalized with sepsis?
Cohort (n=3,018)
Yes
Does previous outpatient use of statins and/or ARBs reduce 30-day mortality in patients hospitalized with sepsis?
Odds Ratio: 0.48 (95% CI 0.36–0.64)
Previous outpatient use of statins or ARBs is associated with significantly reduced 30-day mortality in patients hospitalized with sepsis.
Statin/ARB use was associated with lower sepsis mortality; hypothesis-generating and should not yet change practice.
STUDY OBJECTIVE: To examine the effect of previous outpatient use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and/or angiotensin II receptor blockers (ARBs) on 30-day mortality in patients hospitalized with sepsis. DESIGN: Retrospective national cohort study. DATA SOURCE: Department of Veterans Affairs (VA) national patient care and pharmacy databases. PATIENTS: A total of 3018 patients who were hospitalized with sepsis in fiscal year 2000, had at least 1 year of previous VA outpatient care, and had at least one active and filled VA prescription within 90 days of admission. MEASUREMENTS AND MAIN RESULTS: The primary outcome was 30-day mortality. The primary analysis was a multilevel model with hospital as a random effect and control variables that included comorbid conditions, demographics, and other drugs. Among the 3018 patients hospitalized with sepsis, mean age was 74.4 years, 2975 (98.6%) were male, and 811 (26.9%) died within 30 days of admission. Regarding prescription drug use, 480 patients (15.9%) were taking statins and 107 (3.5%) were taking ARBs. After adjusting for potential confounders, statin use (odds ratio [OR] 0.48, 95% confidence interval [CI] 0.36-0.64) and ARB use (OR 0.42, 95% CI 0.24-0.76) were significantly associated with decreased 30-day mortality. CONCLUSIONS: Use of statins and/or ARBs before admission was associated with decreased mortality in patients hospitalized with sepsis. Further research is needed to determine if these drugs might be started on admission for those with sepsis.
No takes yet. Share an insight, caveat, or question.
Mortensen et al. (2007) conducted a cohort in Sepsis (n=3,018). Statins and/or ARBs vs. Non-users was evaluated on 30-day mortality (OR 0.48, 95% CI 0.36-0.64). Previous outpatient use of statins (OR 0.48; 95% CI 0.36-0.64) or ARBs (OR 0.42; 95% CI 0.24-0.76) was significantly associated with decreased 30-day mortality in patients hospitalized with sepsis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: